The Royal Swedish Academy of Sciences today announced the Nobel Prize in Chemistry winners for 2024, with DeepMind CEO Demis Hassabis and Director John Jumper sharing one-half of the prize ...
David Baker, Demis Hassabis and John M ... findings revealed the link between amino acid sequences and the way they fold into biologically active 3D protein structures. Efforts to identify ...
AI has already disrupted fields like coding, investment banking and law, but it looks to be poised to change yet another ...
There’s an astronomical number of potential shapes a protein could theoretically fold into... which would take longer than the age of the known universe to calculate. Demis Hassabis There’s an ...
David Baker (University of Washington), Demis Hassabis (DeepMind ... Based on this one-dimensional amino acid sequence, proteins fold into complex three-dimensional shapes that enable them ...
Google DeepMind co-founder & CEO Demis Hassabis speaks with columnist Bina Venkataraman about AI’s role in enabling scientific breakthroughs, why human-level intelligence is an “important ...
He is the child from North London who built a multi-million technology company, sold it to Google and is now widely regarded as one of the world's leading experts in artificial intelligence.
This year’s Nobel Prizes were a “watershed moment” for artificial intelligence, according to Demis Hassabis, a co-winner of this year’s prize in chemistry. Hassabis, 48, CEO and co-founder ...
Not many children dream of winning a Nobel Prize when they grow up, but Demis Hassabis did. And win it, he did. In October 2024, the British co-founder and chief executive officer of Google ...
DeepMind CEO Demis Hassabis, whose company is arguably at the front of the race to develop human-level artificial intelligence (AI), said at The Future of Life's Beneficial AI conference in ...
says its founder Sir Demis Hassabis. “We’re looking at oncology, cardiovascular, neurodegeneration, all the big disease areas, and I think by the end of this year, we’ll have our first drug ...